Haryana CM Nayab Singh Saini accuses Congress of misleading poor with false promises for votes. He highlights various housing schemes launched by the BJP government for the benefit of the poor.

Union Minister Rajeev Chandrasekhar stresses regulatory compliance is not optional for fintech firms, highlighting the RBI action on Paytm Payments Bank. Learn about the importance of compliance...

Himachal Pradesh presents a Rs 58,444 crore budget for 2024-25 with focus on agriculture, including increased MSP for milk and a new natural farming scheme.

Adani Wilmar reported a consolidated net profit of Rs 313.20 crore for the April-June quarter, a significant turnaround from a loss in the same period last year.

India's government estimates its debt to rise to Rs 185 lakh crore in FY25, reaching 56.8 per cent of the GDP. The debt includes external borrowing, public account liabilities, and other liabilities.

Central GST officers detected Rs 36,374 crore in fake ITC claims in FY24, a 51% increase from the previous year. The government is taking measures to combat this fraud.

Dr Reddy's Laboratories' biosimilar Rituximab, ITUXREDI, receives positive opinion from the European Medicines Agency (EMA), bringing it closer to launch in EU countries.

UltraTech Cement has confirmed that India Cements will remain a listed entity following its acquisition of a 32.72% stake. The open offer price is Rs 390 per share, and UltraTech intends to acquire...

Adani Wilmar reported a consolidated net profit of Rs 313.20 crore for the April-June quarter, a significant turnaround from a loss in the same period last year.

India's government estimates its debt to rise to Rs 185 lakh crore in FY25, reaching 56.8 per cent of the GDP. The debt includes external borrowing, public account liabilities, and other liabilities.

Central GST officers detected Rs 36,374 crore in fake ITC claims in FY24, a 51% increase from the previous year. The government is taking measures to combat this fraud.

Dr Reddy's Laboratories' biosimilar Rituximab, ITUXREDI, receives positive opinion from the European Medicines Agency (EMA), bringing it closer to launch in EU countries.

UltraTech Cement has confirmed that India Cements will remain a listed entity following its acquisition of a 32.72% stake. The open offer price is Rs 390 per share, and UltraTech intends to acquire...